CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins (Q57718410)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

Cécile Lagaudriere-Gesbert

21 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Claude Boucheix

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

Le Naour F

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Billard M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Conjeaud H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

English

0 references

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

2657-2665

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

The ins and outs of the transmembrane 4 superfamily

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

The OX-44 molecule couples to signaling pathways and is associated with CD2 on rat T lymphocytes and a natural killer cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

CD9 antigen is an accessory subunit of the VLA integrin complexes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Anti-platelet antibody interactions with Fc gamma receptor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

CD9 plays a role in Schwann cell migration in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Ectopic Expression of Human and Feline CD9 in a Human B Cell Line Confers β1 Integrin-dependent Motility on Fibronectin and Laminin Substrates and Enhanced Tyrosine Phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Suppression of human melanoma cell growth and metastasis by the melanoma‐associated antigen CD63 (ME491)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

A new set of monoclonal antibodies against acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Modulation of expression of class II histocompatibility antigens by secretion of a cellular inhibitor in K562 leukemic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Molecular cloning of the mouse equivalent of CD9 antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Specific association of CD63 with the VLA-3 and VLA-6 integrins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Antibodies to different members of the β1 (CD29) integrins induce homotypic and heterotypic cellular aggregation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

An alternative leukocyte homotypic adhesion mechanism, LFA-1/ICAM-1-independent, triggered through the human VLA-4 integrin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G-specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830261117

7 January 2021

Identifiers

DOI

10.1002/EJI.1830261117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8921952%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference